- Advertisement -
At a time when shedding pounds may be just a shot away, WeightWatchers is returning to its roots and its community to chart a new path forward.
Fresh off a major restructuring, the 62-year-old grand dame of weight loss is finding its footing in a market that’s more competitive than ever. Drugs like Novo Nordisk A/S’s Wegovy and Eli Lilly & Co.’s Zepbound help people shed up to 20 percent of their body weight in months, but offer little in the way of support when it comes to side…
